Detailed description page of B3Pdb
This page provides detail information of Selected ID b3pdb_1222 |
| Primary information | |
|---|---|
| B3PDB ID | b3pdb_1222 |
| Peptide Name | AP9 |
| PEPTIDE SEQUENCE (1-letter) | NPNDKYEPF |
| PEPTIDE SEQUENCE (3-letter) | NA |
| N-terminal modification | NA |
| C-terminal modification | C-terminal amidation |
| Chemical modification | NA |
| Peptide Length | 9 |
| Conformation | Linear |
| Peptide Nature | NA |
| Source/Origin of peptide | Chemically synthesized |
| SMILES | NA |
| Cell Line | NA |
| In vitro CONCENTRATION | NA |
| In vitro METHOD | NA |
| In vitro RESULT | NA |
| ANIMAL MODEL | Mice |
| In vivo CONCENTRATION | 20 mg/kg |
| In vivo MODE OF DELIVERY | Intravenous |
| In vivo METHOD | Evans blue dye |
| In vivo RESULT | The preservation of the protective effect of double AP9 administration in the postischemic period. |
| ACTION | It induce β-arrestin-2-dependent cytoprotective pathways. |
| TRANSPORT TYPE | NA |
| SUBCELLULAR LOCALISATION | NA |
| COMBINATION | Alone |
| PHYSICAL CONDITION | Photothrombosis - induced ischemia |
| RESPONSE | NA |
| RESULT | NA |
| LABEL | NA |
| PMID | 32547356 |